hotspot -WSS

hotspot

author：entertainment 2025-10-01 18:07:44 - browse：7798

The FDA building -- First Opinion coverage from STAT — Adobe

A panel of independent advisers to the Food and Drug Administration voted overwhelmingly against a polarizing potential treatment for ALS on Wednesday, concluding that the medicine’s messy supporting data did not meet the standard for approval.

After a day-long meeting that included impassioned testimony from ALS patients, the agency’s expert advisers voted 17-1 with one abstention that the case for NurOwn, a treatment from BrainStorm Cell Therapeutics, was based too heavily on convoluted clinical trial results and compelling but unreliable anecdotal evidence.

“Patients and families need hope, but providing false hope can be ethically problematic,” said panelist Lisa Lee, a bioethicist at Virginia Tech. “False hope is provided when the probability of a positive outcome is overestimated, and I think that seems to be the case here.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： State Dept. review finds Biden bears some blame for Afghanistan failures
Next article： Readout LOUD podcast: A CRISPR milestone, biotech mixology

focus

WSS

FDA's Pazdur wants cancer trials to range beyond China alone

Letters to First Opinion on caregivers, digital health, and more

ASCO: AstraZeneca's Tagrisso greatly slowed some lung cancers

Change Healthcare can notify patients about the breach, HHS says

Weight loss drug costs may need more research, senator suggests

PBM reforms clear House panel

leisure time

hotspot

knowledge

Jerome Adams on the need for new antivirals for Covid

Ionis drug prevents swelling attacks due to hereditary angioedema

United colonoscopy coverage change 'may cost lives,' doctors say

BMI, flaws aside, is found to be useful estimate of body fat in youth

Medicare details structure of new drug price negotiation program

HIV drugs protect against transmission, even in unprotected sex

Medicare details structure of new drug price negotiation program

Change Healthcare can notify patients about the breach, HHS says

Continuity nursing helped my family in our darkest PICU moments

Gain of function research would be limited under House proposal

leisure time

NYU radiologists take on the challenge of expensive MRI machines

U.K. considers world's first use of meningitis vaccine to address gonorrhea

Why medical students are struggling with mental health

A daunting task: navigating dual Medicare, Medicaid eligibility

BMI, flaws aside, is found to be useful estimate of body fat in youth

Weight loss drug Wegovy cuts risk of heart attacks in milestone trial

focus

Wikipedia

hotspot

explore